Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.

Minako WakasugiAkio YokosekiMasakazu WadaTakeshi MomotsuKenji SatoHiroyuki KawashimaKazutoshi NakamuraOsamu OnoderaIchiei Narita

Published in: Journal of bone and mineral metabolism (2021)

Hyperpolypharmacy is associated with an increased risk of fragility fracture regardless of CKD status, and has a strong impact on incident fragility fractures in dialysis-dependent CKD patients.

Keyphrases

chronic kidney disease
end stage renal disease
peritoneal dialysis
cardiovascular disease
ejection fraction
type diabetes
emergency department
prognostic factors
electronic health record